Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7180
+0.0229 (3.29%)
Jun 24, 2025, 4:00 PM - Market closed
NAUT's stock price has decreased by -70.69% in the past year and price targets may not have had time to catch up.
Nautilus Biotechnology Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
$3.88
Upside
+440.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $2.25 → $1.75 | Hold → Strong Sell | Downgrades | $2.25 → $1.75 | +143.73% | Dec 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +735.65% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +317.83% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +735.65% | Aug 3, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +735.65% | Aug 3, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +178.55% | Aug 3, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +457.10% | Jul 14, 2022 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $5 | Hold | Maintains | $9 → $5 | +596.38% | Apr 13, 2022 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $8 | Hold | Initiates | $8 | +1,014.21% | Jan 6, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 2, 2021 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $10 | Hold | Initiates | $10 | +1,292.76% | Aug 4, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +1,710.58% | Jul 13, 2021 |